about
Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout.Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.Modulation of genetic associations with serum urate levels by body-mass-index in humansBody mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and goutThe renal urate transporter SLC17A1 locus: confirmation of association with gout.Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples.The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets.Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge.Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects.Association of the lipoprotein receptor-related protein 2 gene with gout and non-additive interaction with alcohol consumption.Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.Clinical and genetic features of diuretic-associated gout: a case-control study.Association analysis of the beta-3 adrenergic receptor Trp64Arg (rs4994) polymorphism with urate and gout.Influence of genetic variants on renal uric acid handling in response to frusemide: an acute intervention study.Population-specific effects of SLC17A1 genotype on serum urate concentrations and renal excretion of uric acid during a fructose load.The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool.Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis.Response to: 'The reference levels of serum urate for clinically evident incident gout' by Chen and Ding.Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin-8 (CXCL8), Myeloid-Related Protein 8/Myeloid-Related Protein 14 Complex, and an Altered Proteome Are Associated With Diabetes Mellitus and Cardiovascular Disease.ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with goutHyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of uratePopulation-specific influence ofSLC2A9genotype on the acute hyperuricaemic response to a fructose loadReplication of association of the interleukin 23 receptor rs1343151 variant with rheumatoid arthritis in Caucasian sample setsAnalysis of association of DNASE2 promoter variation with rheumatoid arthritis in European CaucasiansSmad2:A Candidate Gene for the Murine Autoimmune Diabetes LocusIdd21.1A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample setsEvidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's diseaseImmunostimulatory biodegradable implants containing the adjuvant Quil-A—Part II:In vivoevaluationA non-coding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expressionThe ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
P50
Q34607608-E49C9A9F-2CB6-4D6B-9768-D2B69E00FE02Q35116125-2DDB361E-9C02-4ACF-B69A-C9BFAF1DF1A3Q35220236-C8BCA85B-25D7-4CE1-BEB3-91F22A085A96Q36082979-F3BEBC73-990F-44BF-8530-FAEF600ABD88Q36245877-D3091BE3-75B2-4D74-89DC-0F70A92434B9Q36896439-560EC071-EA48-4C0A-A7A8-D9D1FD22DC0EQ37453924-B7F9AB40-CB7E-4259-8503-3BBA50AC08FCQ37690064-77B8AD78-C36F-4B51-AE12-A4EE4F0B4174Q37690696-E1C2AD3E-B40C-4C52-BDBB-A30FB6DDE159Q37690975-06C4471A-AF74-4C4C-A0E6-D58AE07F5560Q39838705-26789A7F-59E9-4089-82B3-CB9CA182ADD3Q39910796-A88730C0-220B-4234-AD28-5E6A2C5C5382Q40496098-A094F2E6-821F-4AC6-9BA7-4E3A7672DD65Q41690336-431D5FE5-2EEF-4EFD-8564-ED41106FB539Q46103292-D1143991-3A94-4AD5-A9AD-38CE6CB59F73Q48228865-83395B46-C5BA-447B-93B9-E82C79401B18Q48524891-BCE78DB3-10C3-475A-A2AF-988A855A8F1DQ49792203-0DD2A4B2-A517-48D3-BDF2-316856F9C18BQ52644176-BE9A13F2-CBAB-4B15-BB2A-E9C9D1AE381AQ53590616-7FB7F8DB-08C4-4C43-8420-AD3839117E85Q57154626-95D01AEB-229C-4A91-8487-B292535FF9B7Q57154639-5713B8AC-7C9F-4787-ABBD-5F9D8BBAAED3Q57154755-E4703F25-DDF5-478C-B120-2DEFADC89AFEQ57154811-7FC82E3C-C09F-4E09-AFE4-4442D5A1A733Q57154823-015F29DC-83CB-4E88-B483-093FF556D046Q57154860-CFEF2139-1848-459D-9FD0-F986C46FA379Q57154884-0572FD9A-40F9-4819-B60F-C6E97F764043Q57154899-F3928142-1CD9-44E4-A81F-EE3D0F6F015FQ59234959-C228FE7A-22E1-4B71-B2AD-CF419FC23285Q91037311-BB5AE082-C2B4-4814-98AB-39E070E1E0E4Q96127413-4DE68594-CDA9-48A0-8720-D2F4997201F8
P50
description
researcher ORCID ID = 0000-0002-1763-9623
@en
wetenschapper
@nl
name
Amanda J Phipps-Green
@ast
Amanda J Phipps-Green
@en
Amanda J Phipps-Green
@es
Amanda J Phipps-Green
@nl
type
label
Amanda J Phipps-Green
@ast
Amanda J Phipps-Green
@en
Amanda J Phipps-Green
@es
Amanda J Phipps-Green
@nl
altLabel
Phipps-Green A
@en
prefLabel
Amanda J Phipps-Green
@ast
Amanda J Phipps-Green
@en
Amanda J Phipps-Green
@es
Amanda J Phipps-Green
@nl
P106
P1153
23991012300
P21
P31
P496
0000-0002-1763-9623